Literature DB >> 7721478

Characterization of aneurysmal transformation in perimembranous ventricular septal defects: an adhered anterior leaflet of tricuspid valve predisposes to the development of left ventricular-to-right atrial shunt.

M H Wu1, C I Chang, J K Wang, H C Lue.   

Abstract

BACKGROUND: The most common type of left ventricular-to-right atrial shunts are those associated with perimembranous ventricular septal defect when the defects diminish in size via aneurysmal transformation. This study is to characterize the echocardiographic features and to determine the possible mechanisms. METHODS AND
RESULTS: From January 1986 to December 1992, of 930 consecutive patients with isolated perimembranous ventricular septal defect, 692 showed evidence of aneurysmal transformation. Excluding those with subaortic ridge, echocardiographic analysis was based on 664 of them. Of these, 94 patients had left ventricular-to-right atrial shunts, 115 had their defects spontaneously closed and in 455 only interventricular shunt persisted. Four types of echocardiographic findings featured in the aneurysmal transformation process: type A, both the anterior and septal leaflets of tricuspid valve contributed to the process; type B was similar to type A, but the arc-like structure from the anterior leaflet is much less evident; in type C, only the septal leaflet, and in type D, other adjacent tissues, contribute to the aneurysmal transformation. Type A morphology was closely associated with the development of left ventricular-to-right atrial shunt while types C and D were most commonly seen in those spontaneously closed defects and those with only interventricular shunt. The vegetations of infective endocarditis were located at the atrial side of the tricuspid valve in patients with left ventricular-to-right atrial shunts, while they were in the right ventricle in those with only interventricular shunt.
CONCLUSION: The morphology of the aneurysmal transformation in perimembranous ventricular septal defect can be characterized by echocardiograms. Although the septal leaflet of the tricuspid valve is usually involved in this process, it is the incorporation of the anterior leaflet that predisposes to the development of left ventricular-to-right atrial shunts.

Entities:  

Mesh:

Year:  1994        PMID: 7721478     DOI: 10.1016/0167-5273(94)90177-5

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

1.  Transcatheter Closure of Perimembranous Ventricular Septal Defects with Left Ventricular to Right Atrial Shunt.

Authors:  Gunter Kerst; Axel Moysich; Siew Yen Ho; Christian Apitz; Heiner Latus; Dietmar Schranz
Journal:  Pediatr Cardiol       Date:  2015-04-17       Impact factor: 1.655

2.  Membranous septal aneurysm: an unusual cause for right ventricular outflow tract obstruction in a malaligned ventricular septal defect with aortomitral discontinuity (double-outlet right ventricle) associated with visceral heterotaxy.

Authors:  Sasidharan Bijulal; Sivasubramanian Sivasankaran; Ganapathy Sanjay; Jaganmohan Tharakan
Journal:  Pediatr Cardiol       Date:  2008-08-15       Impact factor: 1.655

3.  Higher Incidence of Atrial Fibrillation in Left Ventricular-to-Right Atrial Shunt Patients.

Authors:  Hongda Chou; Hongxia Chen; Juan Xie; Aiqing Xu; Guanyu Mu; Fei Han; Gary Tse; Guangping Li; Tong Liu; Huaying Fu
Journal:  Front Physiol       Date:  2020-12-07       Impact factor: 4.566

4.  Investigation of membranous ventricular septal defect complicated with tricuspid regurgitation in ventricular septal defect occlusion.

Authors:  Shu-Ping Liu; Li Li; Ke-Chun Yao; Na Wang; Jian-Chang Wang
Journal:  Exp Ther Med       Date:  2012-12-21       Impact factor: 2.447

Review 5.  Gerbode defect: A comprehensive review of its history, anatomy, embryology, pathophysiology, diagnosis, and treatment.

Authors:  Erfanul Saker; Ghazal N Bahri; Michael J Montalbano; Jaspreet Johal; Rachel A Graham; Gabrielle G Tardieu; Marios Loukas; R Shane Tubbs
Journal:  J Saudi Heart Assoc       Date:  2017-02-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.